BIOR - BIORA THERAPEUTICS, INC.
0.5461
-0.214 -39.169%
Share volume: 0
Last Updated: Tue 10 Dec 2024 09:29:11 PM CET
Research and Development in Biotechnology (except Nanobiotechnology):
-0.07%
PREVIOUS CLOSE
CHG
CHG%
$0.76
-0.21
-28.14%
View ratios
| Fiscal Date | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | |
|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | |
| Report Date | 2023-05-15 | 2023-08-14 | 2023-11-13 | 2024-04-01 | 2024-05-15 | |
| Total revenue | 2.000 K | 2.000 K | 0.000 | 0.000 | 542.000 K | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 2.000 K | 2.000 K | 0.000 | 0.000 | 542.000 K | |
| 0.00% | -100.00% | nan% | inf% | |||
| Operating expenses | 15.546 M | 14.936 M | 23.321 M | 13.344 M | 16.058 M | |
| Selling general and admin | 8.356 M | 8.953 M | 12.774 M | 7.226 M | 9.053 M | |
| Research and development | 7.190 M | 5.983 M | 10.547 M | 6.118 M | 7.005 M | |
| Total expenses | 15.546 M | 14.936 M | 23.321 M | 13.344 M | 16.058 M | |
| -3.92% | 56.14% | -42.78% | 20.34% | |||
| Operating income | -15.544 M | -14.934 M | -23.321 M | -13.344 M | -15.516 M | |
| Ebit | -15.544 M | -14.934 M | -23.321 M | -13.344 M | -15.516 M | |
| Pretax income | -17.441 M | -17.803 M | -73.453 M | -15.727 M | -4.141 M | |
| 2.08% | 312.59% | -78.59% | -73.67% | |||
| Income tax | 0.000 | 4.000 K | 1.000 K | -95.000 K | 48.000 K | |
| Net income basic | -17.441 M | -17.807 M | -73.454 M | -15.413 M | -4.189 M | |
| -2.10% | -312.50% | 79.02% | 72.82% | |||
| Net income | -17.441 M | -17.807 M | -73.454 M | -15.413 M | -4.189 M | |
| -2.10% | -312.50% | 79.02% | 72.82% |